查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1373934

糖尿病治疗市场，按治疗类型、疾病、最终用户、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Diabetes Therapeutics Market, By Therapy Type, By Diseases, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 308 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年糖尿病治疗市场规模为 652.001 亿美元，2023 年至 2030 年CAGR为 5.9%。

此外，持续监测、病患教育和积极参与是糖尿病治疗不可或缺的面向。这些元素在实现血糖控制、降低併发症风险以及促进糖尿病患者的长期健康和福祉方面发挥关键作用。

糖尿病治疗市场-市场动态

全球糖尿病盛行率上升推动市场需求

1 型和第 2 型糖尿病的发生率不断上升，通常与久坐的生活方式、不健康的饮食习惯和肥胖等因素有关，导致对有效治疗的需求不断增加。糖尿病诊断和相关併发症数量的不断增加给全球医疗保健系统带来了巨大压力。为此，製药公司和研究人员被迫开发新的治疗方法，包括改良的胰岛素配方、创新的口服药物以及连续血糖监测和人工胰臟系统等尖端技术。解决糖尿病流行已成为医疗保健的首要任务。

糖尿病治疗市场 - 关键见解

根据我们的研究分析师提供的分析，预计 2023 年至 2030 年的预测期内，全球糖尿病治疗市场的年增长率约为 5.9%。

糖尿病治疗产业有望大幅成长，这主要归因于全球糖尿病盛行率的增加。

在治疗类型细分方面，2022年口服降血糖药物成为主导类别。

在疾病细分方面，妊娠糖尿病已成为 2022 年的主要治疗类型。

糖尿病治疗市场-細項分析：

全球糖尿病治疗市场围绕着关键参数构建，包括治疗类型、疾病、最终用户和地区。

在治疗类型类别中，市场分为三个主要部分：口服抗糖尿病药物、注射抗糖尿病药物和其他。值得注意的是，口服抗糖尿病药物领域在市场中占据主导地位。糖尿病治疗领域对口服降血糖药物有着巨大的需求。这些药物通常以药丸或片剂的形式提供，在帮助第 2 型糖尿病患者有效控制血糖水平方面发挥着至关重要的作用。它们是口服治疗的基石，有助于控制血糖和减少併发症。

糖尿病治疗市场 - 地理洞察

糖尿病治疗市场遍布各个地区，包括北美、拉丁美洲、欧洲、亚太地区、中东和非洲，每个地区又根据从事商业活动的各国进一步细分。

值得注意的是，由于多种因素的综合作用，亚太地区对糖尿病药物的需求量很大。首先，该地区的糖尿病盛行率正在激增，这主要是由城市化、久坐的生活方式和饮食习惯的转变所推动的。这些因素共同导致亚太地区对有效糖尿病治疗的需求不断增长。

糖尿病治疗市场-竞争格局：

糖尿病药物市场呈现动态和竞争格局，主要製药巨头和新兴生技公司处于领先地位。胰岛素领域的主要竞争对手，包括诺和诺德(Novo Nordisk)、赛诺菲(Sanofi) 和礼来(Eli Lilly)，透过开发和提供广泛的胰岛素疗法、注射GLP-1 受体激动剂和口服糖尿病药物发挥着至关重要的作用。

此外，Dexcom 和 Medtronic 等设备製造商透过提供连续血糖监测系统和胰岛素输送设备、向市场推出创新解决方案并增强糖尿病患者的治疗选择，为这种竞争环境做出了贡献。

目录

第一章：糖尿病治疗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场摘录
    • 依疾病分类的糖尿病治疗市场摘录
    • 按治疗类型分類的糖尿病治疗市场摘录
    • 最终使用者的糖尿病治疗市场摘录
    • 按国家/地区分類的糖尿病治疗市场摘录
    • 按地区分類的糖尿病治疗市场摘录
  • 竞争洞察

第 3 章：糖尿病治疗主要市场趋势

  • 糖尿病治疗市场驱动因素
    • 市场驱动因素的影响分析
  • 糖尿病治疗市场限制
    • 市场限制影响分析
  • 糖尿病治疗市场机会
  • 糖尿病治疗市场未来趋势

第 4 章：糖尿病治疗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：糖尿病治疗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：糖尿病治疗市场格局

  • 2022 年糖尿病治疗市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：糖尿病治疗市场 - 按疾病分类

  • 概述
    • 按疾病分类的细分市场占有率分析
    • 1 型糖尿病
    • 2型糖尿病
    • 妊娠糖尿病

第 8 章：糖尿病治疗市场 - 依治疗类型

  • 概述
    • 按治疗类型分類的细分市场份额分析
    • 口服抗糖尿病药
    • 注射型抗糖尿病药
    • 其他的

第 9 章：糖尿病治疗市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院和诊所
    • 居家护理
    • 其他的

第 10 章：糖尿病治疗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美糖尿病治疗主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模与预测（按疾病）
    • 北美市场规模和预测（按治疗类型）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲糖尿病治疗药物主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按疾病）
    • 欧洲市场规模和预测（按治疗类型）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区糖尿病治疗主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按疾病）
    • 亚太地区市场规模与预测（按治疗类型）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲糖尿病治疗主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按疾病）
    • 拉丁美洲市场规模与预测（按治疗类型）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲糖尿病治疗药物主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按疾病）
    • 中东和非洲市场规模和预测（按治疗类型）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 糖尿病治疗产业

  • 竞争仪表板
  • 公司简介
    • Astrazeneca PLC
    • Boehringer Ingelheim GmbH
    • Eli Lilly and Company
    • GlaxoSmithKline PLC
    • Novartis AG
    • Novo Nordisk
    • Sanofi SA
    • Takeda Pharmaceutical Company Limited
    • Johnson and Johnson Md&D
    • Merck and Co. Inc.

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV1798

REPORT HIGHLIGHT

Diabetes Therapeutics Market size was valued at USD 65,200.1 Million in 2022, expanding at a CAGR of 5.9 % from 2023 to 2030.

Diabetes therapies encompass a diverse range of medical strategies and interventions devised for the management of diabetes mellitus, a chronic metabolic disorder characterized by elevated blood sugar levels. These therapeutic approaches are aimed at aiding individuals with diabetes in regulating their blood glucose levels, preventing complications, and ultimately improving their overall quality of life. The spectrum of diabetes treatment options includes dietary and lifestyle modifications, as well as oral medications, injectable insulin, and various pharmacological interventions.

Moreover, continuous monitoring, patient education, and active involvement are integral aspects of diabetes therapies. These elements play a pivotal role in achieving glycemic control, reducing the risk of complications, and fostering the long-term health and well-being of individuals living with diabetes.

Diabetes Therapeutics Market- Market Dynamics

Global rise in diabetes prevalence propels market demand

The escalating incidence of both type 1 and type 2 diabetes, often associated with factors such as sedentary lifestyles, unhealthy dietary habits, and obesity, has led to an increasing demand for effective therapies. The mounting number of diabetes diagnoses and related complications is placing substantial pressure on healthcare systems worldwide. In response, pharmaceutical companies and researchers are driven to develop novel treatments, including improved insulin formulations, innovative oral medications, and cutting-edge technologies such as continuous glucose monitoring and artificial pancreas systems. Addressing the diabetes epidemic has emerged as a paramount healthcare priority.

Diabetes Therapeutics Market- Key Insights

Based on the analysis provided by our research analyst, the global market for Diabetes Therapeutics is anticipated to experience an annual growth rate of approximately 5.9% over the forecast period spanning from 2023 to 2030.

The Diabetes Therapeutics industry is poised for substantial growth, largely attributed to the global increase in the prevalence of diabetes.

In terms of Therapy Type segmentation, the year 2022 witnessed Oral Antidiabetics as the dominant category.

Regarding Diseases segmentation, Gestational diabetes emerged as the leading Therapy Type in 2022.

Diabetes Therapeutics Market- Segmentation Analysis:

The Global Diabetes Therapeutics Market is structured around key parameters, including Therapy Type, Diseases, End User, and Region.

Within the Therapy Type category, the market is categorized into three primary segments: Oral Antidiabetics, Injectable Antidiabetics, and Others. Notably, the Oral Antidiabetics sector assumes a dominant position within the market. There is significant demand for oral antidiabetics in the field of diabetes therapeutics. These medications, often available in the form of pills or tablets, play a vital role in helping individuals with type 2 diabetes manage their blood sugar levels effectively. They are a cornerstone of oral treatment, contributing to glucose control and the reduction of complications.

Diabetes Therapeutics Market- Geographical Insights

The market for diabetes therapeutics spans across various regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa, with each region further segmented by individual countries engaged in business activities.

Notably, there is a substantial demand for diabetes medications in the Asia-Pacific region, attributed to several converging factors. Firstly, the region is witnessing a surge in diabetes prevalence, primarily fueled by urbanization, sedentary lifestyles, and dietary shifts. These factors collectively contribute to the growing need for effective diabetes treatments in the Asia-Pacific region.

Diabetes Therapeutics Market- Competitive Landscape:

The diabetes medications market features a dynamic and competitive landscape, with major pharmaceutical giants and emerging biotech companies at the forefront. Prominent competitors in the insulin sector, including Novo Nordisk, Sanofi, and Eli Lilly, play a crucial role by developing and offering a wide range of insulin therapies, injectable GLP-1 receptor agonists, and oral diabetes medications.

Furthermore, device manufacturers like Dexcom and Medtronic contribute to this competitive environment by providing continuous glucose monitoring systems and insulin delivery devices, introducing innovative solutions to the market and enhancing the treatment options available to individuals living with diabetes.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DIABETES THERAPEUTICS MARKET KEY PLAYERS

  • Astrazeneca PLC
  • Boehringer Ingelheim GmbH
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • Novartis AG
  • Novo Nordisk
  • Sanofi SA
  • Takeda Pharmaceutical Company Limited
  • Johnson and Johnson Md&D
  • Merck and Co. Inc.

GLOBAL DIABETES THERAPEUTICS MARKET, BY THERAPY TYPE

  • Oral Antidiabetics
  • Injectable Antidiabetics
  • Others

GLOBAL DIABETES THERAPEUTICS MARKET, BY DISEASES

  • Type 1 diabetes
  • Type 2 diabetes
  • Gestational diabetes

GLOBAL DIABETES THERAPEUTICS MARKET, BY END USER

  • Hospitals and Clinics
  • Homecare
  • others

GLOBAL DIABETES THERAPEUTICS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Diabetes Therapeutics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Diabetes Therapeutics Market Snippet by Diseases
    • 2.1.2. Diabetes Therapeutics Market Snippet by Therapy Type
    • 2.1.3. Diabetes Therapeutics Market Snippet by End User
    • 2.1.4. Diabetes Therapeutics Market Snippet by Country
    • 2.1.5. Diabetes Therapeutics Market Snippet by Region
  • 2.2. Competitive Insights

3. Diabetes Therapeutics Key Market Trends

  • 3.1. Diabetes Therapeutics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Diabetes Therapeutics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Diabetes Therapeutics Market Opportunities
  • 3.4. Diabetes Therapeutics Market Future Trends

4. Diabetes Therapeutics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Diabetes Therapeutics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Diabetes Therapeutics Market Landscape

  • 6.1. Diabetes Therapeutics Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Diabetes Therapeutics Market - By Diseases

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Diseases, 2022 & 2030 (%)
    • 7.1.2. Type 1 diabetes
    • 7.1.3. Type 2 diabetes
    • 7.1.4. Gestational diabetes

8. Diabetes Therapeutics Market - By Therapy Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Therapy Type, 2022 & 2030 (%)
    • 8.1.2. Oral Antidiabetics
    • 8.1.3. Injectable Antidiabetics
    • 8.1.4. Others

9. Diabetes Therapeutics Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
    • 9.1.2. Hospitals and Clinics
    • 9.1.3. Homecare
    • 9.1.4. others

10. Diabetes Therapeutics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Diabetes Therapeutics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Diabetes Therapeutics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Diabetes Therapeutics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Diabetes Therapeutics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Diabetes Therapeutics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Diabetes Therapeutics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Astrazeneca PLC
    • 11.2.2. Boehringer Ingelheim GmbH
    • 11.2.3. Eli Lilly and Company
    • 11.2.4. GlaxoSmithKline PLC
    • 11.2.5. Novartis AG
    • 11.2.6. Novo Nordisk
    • 11.2.7. Sanofi SA
    • 11.2.8. Takeda Pharmaceutical Company Limited
    • 11.2.9. Johnson and Johnson Md&D
    • 11.2.10. Merck and Co. Inc.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data Therapy Types
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Diabetes Therapeutics Market: Diseases Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Diseases
  • TABLE Global Diabetes Therapeutics Market, by Diseases 2018-2030 (USD Million)
  • TABLE Diabetes Therapeutics Market: Therapy Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Therapy Type
  • TABLE Global Diabetes Therapeutics Market, by Therapy Type 2018-2030 (USD Million)
  • TABLE Diabetes Therapeutics Market: End User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Diabetes Therapeutics Market, by End User 2018-2030 (USD Million)
  • TABLE Diabetes Therapeutics Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Diabetes Therapeutics Market, by Region 2018-2030 (USD Million)
  • TABLE North America Diabetes Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Diabetes Therapeutics Market, by Diseases, 2018-2030 (USD Million)
  • TABLE North America Diabetes Therapeutics Market, by Therapy Type, 2018-2030 (USD Million)
  • TABLE North America Diabetes Therapeutics Market, by End User, 2018-2030 (USD Million)
  • TABLE Europe Diabetes Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Diabetes Therapeutics Market, by Diseases, 2018-2030 (USD Million)
  • TABLE Europe Diabetes Therapeutics Market, by Therapy Type, 2018-2030 (USD Million)
  • TABLE Europe Diabetes Therapeutics Market, by End User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Diabetes Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Diabetes Therapeutics Market, by Diseases, 2018-2030 (USD Million)
  • TABLE Asia Pacific Diabetes Therapeutics Market, by Therapy Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Diabetes Therapeutics Market, by End User, 2018-2030 (USD Million)
  • TABLE Latin America Diabetes Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Diabetes Therapeutics Market, by Diseases, 2018-2030 (USD Million)
  • TABLE Latin America Diabetes Therapeutics Market, by Therapy Type, 2018-2030 (USD Million)
  • TABLE Latin America Diabetes Therapeutics Market, by End User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Diabetes Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Diabetes Therapeutics Market, by Diseases, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Diabetes Therapeutics Market, by Therapy Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Diabetes Therapeutics Market, by End User, 2018-2030 (USD Million)